Skip to main content
NexgenRx Inc. (TSXV:NXG)
Canada flag Canada · Delayed Price · Currency is CAD
0.355
+0.015 (4.41%)
Mar 9, 2026, 10:54 AM EST

NexgenRx Revenue

NexgenRx had revenue of 4.62M CAD in the quarter ending September 30, 2025, with 13.43% growth. This brings the company's revenue in the last twelve months to 17.71M, up 11.77% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.

Revenue (ttm)
17.71M
Revenue Growth
+11.77%
P/S Ratio
1.43
Revenue / Employee
885.68K
Employees
20
Market Cap
25.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202416.48M2.63M18.99%
Dec 31, 202313.85M1.07M8.33%
Dec 31, 202212.78M939.94K7.94%
Dec 31, 202111.84M1.27M12.01%
Dec 31, 202010.57M1.03M10.82%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Principal Technologies 370.42K
DIAGNOS 68.16K
Comprehensive Healthcare Systems 5.79M
AI/ML Innovations 168.26K
NetraMark Holdings 165.26K
Kovo+ Holdings 15.06M
Seegnal 1.72M
Hydreight Technologies 24.48M
Revenue Rankings

NexgenRx News

More News